tirzepatide new england journal of medicine Discovery GLP-1–Based Drugs for the Treatment of Obesity SURMOUNT-5: Tirzepatide shows superior weight

These predispositions should be interpreted with a qualified healthcare provider as part of a comprehensive treatment discussion, not as a guarantee of medication response

Im watching for improvements in CRP and other inflammatory indicators because those improvements predict mood benefits

(Industry coverage of Eli Lilly's December 2025 TRIUMPH-4 topline announcement, including the 28.7% body weight loss figure on 12mg, the 2.1% placebo figure, and the schedule for remaining 2026 readouts.) Eli Lilly and Company

the utility of point-of-care gastric ultrasound in assessing aspiration risk in this population

The expression of NAMPT increased tumor cell proliferation, ERK-1/2 and p38 activity levels, the expression levels of metalloproteases, colony formation, and resistance to apoptosis

Journal of Cardiovascular Translational Research, 12 (6), 600607